Data and Statistics Support for Myeloproliferative Neoplasms
Core C: Biostatistics and Data Management Core
This core provides data management and statistical support to improve clinical trials and tumor-bank research for people with myeloproliferative neoplasms.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11094815 on NIH RePORTER |
What this research studies
A team led with Mayo Clinic expertise organizes and analyzes the data behind clinical trials and the tumor bank for myeloproliferative neoplasms so results are reliable. They help design trials and lab studies, analyze patient-reported outcomes and complex biomarker data, and perform statistical monitoring and modeling. All clinical and specimen data are captured in a secure, web-based REDCap system so participating clinics share consistent information. From a patient view, this means studies you join are more carefully run and the findings are more trustworthy.
Who could benefit from this research
Good fit: Ideal candidates are people with a diagnosis of a myeloproliferative neoplasm who enroll in MPN-RC clinical trials or agree to donate tissue or data to the consortium's tumor bank.
Not a fit: People without MPN or those not enrolled in MPN-RC studies or not providing samples would not directly benefit from this core's work.
Why it matters
Potential benefit: If successful, this core could lead to better-designed MPN trials, clearer results from biomarker and tissue studies, and faster progress toward effective treatments.
How similar studies have performed: Biostatistics and data-management cores are an established model that have improved the quality and reliability of many clinical trials and biomarker studies.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Dueck, Amylou Constance — Icahn School of Medicine at Mount Sinai
- Study coordinator: Dueck, Amylou Constance
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.